Aktiesnakken — Oktober 2010
-
FCM -60 mio kr
-
58,4*
-
mornings
-
hvordan så intel ud?
-
11 billion revenue quarter!
-
eps på 52....så de er ontrack på p/e 10...http://www.intc.com/releasedetail.cfm?ReleaseID=517718&ReleasesType=Financial News
-
hvad ligger det i den gentogen? effekt data?
-
ser den nu....
-
nope
-
vi vil hellere have value
-
apple, intel
-
som jeg læser de data er der med 90% sikkerhed 99,8% relativ forbedret effekt overfor placebo
-
det er selvfølgelig ikke 100% orr, men mig og varnæs accepterer det
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind